Glycomine

Series-B
glycomine.com Biotech & Healthcare San Carlos, United States Founded 2014 11–50 employees
Total Funding $195M
Latest Round $115M Series-B
Last Announced May 9, 2025
Investors 14 Backers
Decision Makers 6 Available

About Glycomine

We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters San Carlos, United States
Year Founded 2014
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website glycomine.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @GlycomineBio (52 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $115,000,000 · Series-B

    Backed by Advent Life Sciences

  2. Capital Raise

    Raised $68,000,000 · Series-B

    Backed by Abingworth

  3. Capital Raise

    Raised $12,000,000 · Series-A

    Backed by Chiesi Ventures

  4. Milestone

    Company founded

    San Carlos, United States

Investors & Backers

14
Abingworth
Lead
Advent Life Sciences
Lead
Chiesi Ventures
Lead
Aberdeen
Asahi Kasei
Asahi Kasei Corporate Venture Capital
CTI Life Sciences Fund
Mesa Verde Venture Partners
Mission BioCapital
Novo Holdings
Remiges Ventures
RiverVest
Sanderling Ventures
Sanofi Ventures

Funding History

3 Rounds
Series-B equity · May 9, 2025

Round backers: Advent Life Sciences

Series-B equity · Jun 23, 2021

Round backers: Abingworth

$68,000,000 businesswire.com
Series-A equity · Nov 16, 2016

Round backers: Chiesi Ventures

Founders & Leadership

5

Agnes Rafalko

Founder

Work email & phone locked Unlock →

Deirdre Foley

Director of R&D, Biology

Work email & phone locked Unlock →

Peter McWilliams

CEO

Work email & phone locked Unlock →

Rose Marino

Chief Medical Officer

Work email & phone locked Unlock →

Steven Axon

Chief Executive Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts